FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Rifampin/Isoniazid (Rifamate) Capsules
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Sanofi-Aventis (New 06/15/2020)

Company Contact Information:
800-633-1610; Option 7

Presentation Posting Date Related Information
150 mg/300 mg capsules (NDC 0068-0509-60) 06/15/2020

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English